Zacks Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Zacks Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,493	Closed	-$374K	–	603
2020 Q1	$374K	Sell	9,493 -1,157	-11%	-$67.7K	0.01%	413
2019 Q4	$633K	Buy	10,650 +1,163	+12%	+$62.5K	0.01%	430
2019 Q3	$505K	Buy	+9,487	New	+$487K	0.01%	438
2016 Q3	–	Sell	-17,885	Closed	-$682K	–	745
2016 Q2	$682K	Sell	17,885 -29,157	-62%	-$1.28M	0.02%	400
2016 Q1	$1.94M	Buy	47,042 +5,880	+14%	+$242K	0.06%	204
2015 Q4	$2M	Sell	41,162 -4,728	-10%	-$210K	0.07%	197
2015 Q3	$1.84M	Buy	+45,890	New	+$2M	0.06%	198

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zacks Investment Management's SYNH Position: Q2 2020 in Review

Zacks Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2020, closing a stake of 9,493 shares — an estimated $374K sold.

Zacks Investment Management first reported a position in SYNH in Q3 2015 and held it in 7 quarters. The position peaked at $2M in Q4 2015. 285 funds tracked by Wall St. Rank hold SYNH as of Q2 2020.

Zacks Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
Zacks Investment Management sold 9,493 Syneos Health, Inc. Class A Common Stock shares in Q2 2020, an estimated $374K.
Zacks Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 7 quarters.
Zacks Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $2M in Q4 2015.
285 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2020.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.